NHS National Framework for Medical Retinal Vascular Treatments 1 August 2024
NHS England · awarded 25 July 2024
£416.8m
Award value
£416,830,570
9
Suppliers
Size not recorded
31 Jul 2025
Runs until
from 1 Aug 2024
Who
| Buyer | NHS England Runcorn |
|---|---|
| Suppliers |
Abbvie Ltd Alimera Sciences Bayer Plc Biogen Novartis Pharmaceuticals UK Ltd Orion Pharma (UK) Ltd Roche Products Ltd Teva UK Limited Thornton and Ross Ltd |
| Category | goods |
| Classification | Pharmaceutical products CPV 33600000 |
| Notice published | 23 August 2024 |
What it is for
roject title: CM/PHS/24/5707 NHS National Framework for Medical Retinal Vascular Treatments 1 August 2024 Period of framework: 1 August 2024 to 31 July 2025. with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months
Read the original award notice on Contracts Finder →
Other contracts from this buyer
1269 awards on file, worth £50.2bn.
| Awarded | What for | Buyer | Supplier | Value |
|---|---|---|---|---|
| 4 Mar 2026 | New Hospital Programme - Hospital 2.0 Alliance (H2A) FrameworkEngland | NHS England | Willmott Dixon Construction Limited +9 | £37.0bn |
| 24 Mar 2025 | NHS Framework Agreement for Branded Medicines - Proprietary Category TenderEast Midlands | NHS England | CSL Behring UK Ltd +71 | £1.2bn |
| 1 Jul 2025 | NHS Branded Medicines Tranche B - MAE & NOFE - 1 September 2025 | NHS England | Biogen +20 | £986.3m |
| 19 Dec 2024 | NHS Framework Agreement for Human Albumin & Normal and Anti-D ImmunoglobulinScotland | NHS England | CSL Behring UK Ltd +5 | £905.2m |
| 31 May 2024 | NHS Framework - Blood Disorders including Haemophilia A and B - July 2024East Midlands | NHS England | Pfizer Ltd +8 | £765.0m |
Everything NHS England has awarded →
Other contracts won by this supplier
18 awards on file, worth £2.9bn.
| Awarded | What for | Buyer | Supplier | Value |
|---|---|---|---|---|
| 24 Mar 2025 | NHS Framework Agreement for Branded Medicines - Proprietary Category TenderEast Midlands | NHS England | CSL Behring UK Ltd +71 | £1.2bn |
| 25 Jul 2024 | NHS National Framework for Medical Retinal Vascular Treatments 1 August 2024 | NHS England | Bayer Plc +8 | £416.8m |
| 1 Jul 2025 | LPP/2024/001 Contrast Media and Associated Injectors/Consumables | NHS London Procurement Partnership (Hosted by… | Bracco UK Ltd +5 | £382.9m |
| 1 Jul 2025 | LPP/2024/001 Contrast Media and Associated Injectors/Consumables | NHS London Procurement Partnership (Hosted by… | Bracco UK Ltd +5 | £382.9m |
| 25 Jun 2025 | NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National | NHS England | Roche Products Ltd +27 | £261.9m |